Monika M Kutyna

9PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersRegenerative medicine (incl. stem cells)Medical virologyMedical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 22, 2025
RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm.

Chung Hoow Kok, Aref Al-Kali, Daniel Thomas

|Mar 14, 2025
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations.

Mithun Vinod Shah, Kevin Hung, Anmol Baranwal

|Oct 18, 2024
Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment.

Deepak Singhal, Monika M Kutyna, Christopher N Hahn

|Nov 10, 2022
Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability.

Daniel Thomas, Manhong Wu, Yusuke Nakauchi

Pageof 2